A groundbreaking clinical trial has demonstrated that a custom-designed mRNA vaccine developed by Merck and Moderna substantially lowers the likelihood...
melanoma
Merck and Moderna revealed Wednesday that their investigational personalized mRNA cancer vaccine demonstrated efficacy in a substantial phase 3 clinical...
William Shatner, 95, disclosed this week that a physician's early misidentification of a suspicious lump nearly prevented detection of advanced...